{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:17:01Z","timestamp":1790691421561,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10067-026-08255-z","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:18:50Z","timestamp":1782350330000},"page":"4881-4888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Residual symptom absence assessed by Okomarigoto Sheet is independently associated with patient-acceptable symptom state beyond inflammation in rheumatoid arthritis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6680-3445","authenticated-orcid":false,"given":"Kensuke","family":"Koyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ohba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryousuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"3","key":"8255_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1192\/bjp.2023.86","volume":"223","author":"K Hagi","year":"2023","unstructured":"Hagi K, Kurokawa S, Takamiya A, Fujikawa M, Kinoshita S, Iizuka M et al (2023) Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomized controlled trials. Br J Psychiatry 223(3):407\u201314","journal-title":"Br J Psychiatry"},{"issue":"4","key":"8255_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1192\/bja.2022.42","volume":"29","author":"TJ Brunt","year":"2023","unstructured":"Brunt TJ, Gale-Grant O (2023) Telepsychiatry: what clinicians need to know about digital mental healthcare. BJPsych Adv 29(4):230\u20138","journal-title":"BJPsych Adv"},{"issue":"5","key":"8255_CR3","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/tmj.2023.0466","volume":"30","author":"M Cho","year":"2024","unstructured":"Cho M, Kim W, Kim M, Ye R, Hwang Y, Lee DW et al (2024) The effect of telehealth on patterns of health care utilization and medication prescription in patients with diabetes or hypertension during COVID-19: a nationwide study. Telemed J E Health 30(5):1297\u2013305","journal-title":"Telemed J E Health"},{"issue":"8","key":"8255_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306347","volume":"19","author":"MH Hayavi-Haghighi","year":"2024","unstructured":"Hayavi-Haghighi MH, Gharibzade A, Choobin N, Ansarifard H (2024) Applications and outcomes of implementing telemedicine for hypertension management in COVID-19 pandemic: a systematic review. PLoS ONE 19(8):e0306347","journal-title":"PLoS ONE"},{"issue":"8","key":"8255_CR5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/annrheumdis-2022-222341","volume":"81","author":"A de Thurah","year":"2022","unstructured":"de Thurah A, Bosch P, Marques A, Meissner Y, Mukhtyar CB, Knitza J et al (2022) 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Ann Rheum Dis 81(8):1065\u20131071","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8255_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.31138\/mjr.34.1.16","volume":"34","author":"N Barlas","year":"2023","unstructured":"Barlas N, Barlas SB, Basnyat S, Adalier E (2023) Telemedicine in rheumatoid arthritis: a review of the PubMed literature. Mediterr J Rheumatol 34(1):16\u201323","journal-title":"Mediterr J Rheumatol"},{"issue":"12","key":"8255_CR7","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/acr.24429","volume":"73","author":"BR England","year":"2021","unstructured":"England BR, Barber CEH, Bergman M, Ranganath VK, Suter LG, Michaud K (2021) Adaptation of American College of Rheumatology rheumatoid arthritis disease activity and functional status measures for telehealth visits. Arthritis Care Res (Hoboken) 73(12):1809\u20131814","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"8255_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/acr.24485","volume":"74","author":"ED Ferucci","year":"2022","unstructured":"Ferucci ED, Day GM, Choromanski TL, Freeman SL (2022) Outcomes and quality of care in rheumatoid arthritis with or without video telemedicine follow-up visits. Arthritis Care Res (Hoboken) 74(3):484\u2013492","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"8255_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/RHU.0000000000001883","volume":"28","author":"BF Seppen","year":"2022","unstructured":"Seppen BF, Verkleij SJ, Wiegel J, Ter Wee MM, Nurmohamed MT, Bos WH (2022) Probability of medication intensifications in rheumatoid arthritis patients with low disease activity scores on their patient-reported outcomes: a medical-records review study. J Clin Rheumatol 28(8):397\u2013401","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"8255_CR10","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/art.42559","volume":"75","author":"N Arumalla","year":"2023","unstructured":"Arumalla N, Chan CKD, Gibson M, Man YL, Adas MA, Norton S et al (2023) The clinical impact of electronic patient-reported outcome measures in the remote monitoring of inflammatory arthritis: a systematic review and meta-analysis. Arthritis Rheumatol 75(11):1892\u20131903","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"8255_CR11","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/rheumatology\/keab796","volume":"61","author":"M Sloan","year":"2022","unstructured":"Sloan M, Lever E, Harwood R, Gordon C, Wincup C, Blane M et al (2022) Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians. Rheumatology (Oxford) 61(6):2262\u201374","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"8255_CR12","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/ard.2008.100271","volume":"68","author":"L Gossec","year":"2009","unstructured":"Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S et al (2009) Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis 68(11):1680\u20131685","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8255_CR13","first-page":"973","volume":"51","author":"J Avouac","year":"2024","unstructured":"Avouac J, Molto A, Allanore Y (2024) Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) score in assessing rheumatoid arthritis activity in teleconsultation. J Rheumatol 51(10):973\u2013977","journal-title":"J Rheumatol"},{"issue":"10","key":"8255_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3899\/jrheum.2024-0579","volume":"51","author":"PC Taylor","year":"2024","unstructured":"Taylor PC (2024) The Rheumatoid Arthritis Impact of Disease (RAID) score in telemedicine management of rheumatoid arthritis. J Rheumatol 51(10):947\u2013948","journal-title":"J Rheumatol"},{"issue":"1","key":"8255_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/mr\/roac152","volume":"34","author":"Y Kaneko","year":"2023","unstructured":"Kaneko Y, Hasegawa M, Ikeda K, Nakano K, Kadono Y, Tanaka Y et al (2023) Illustrations of rheumatoid arthritis symptoms to promote communication between patients and physicians. Mod Rheumatol 34(1):87\u201391","journal-title":"Mod Rheumatol"},{"issue":"2","key":"8255_CR16","volume":"17","author":"K Koyama","year":"2025","unstructured":"Koyama K, Koizumi R (2025) Potential of a novel patient-reported outcome assessment method utilizing illustrations in rheumatoid arthritis. Cureus 17(2):e79473","journal-title":"Cureus"},{"issue":"9","key":"8255_CR17","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s10067-025-07592-9","volume":"44","author":"K Koyama","year":"2025","unstructured":"Koyama K, Ohba T, Koizumi R, Haro H (2025) Prevalence and predictors of residual symptoms in rheumatoid arthritis patients in SDAI remission: a cross-sectional study using the illustrated Okomarigoto Sheet. Clin Rheumatol 44(9):3497\u20133504","journal-title":"Clin Rheumatol"},{"key":"8255_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roag027","author":"K Koyama","year":"2026","unstructured":"Koyama K, Ohba T, Koizumi R, Watabe K, Sugita C, Haro H (2026) Assessment of residual symptoms using the Okomarigoto sheet can complement evaluation of the patient acceptable symptom state in patients with rheumatoid arthritis. Mod Rheumatol. https:\/\/doi.org\/10.1093\/mr\/roag027","journal-title":"Mod Rheumatol"},{"issue":"1","key":"8255_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/art.22469","volume":"57","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A (2007) Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 57(1):133\u2013139","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8255_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3899\/jrheum.090449","volume":"37","author":"MK Kvamme","year":"2010","unstructured":"Kvamme MK, Kristiansen IS, Lie E, Kvien TK (2010) Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 37(1):26\u201331","journal-title":"J Rheumatol"},{"issue":"11","key":"8255_CR21","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/acr.21747","volume":"64","author":"F Tubach","year":"2012","unstructured":"Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C et al (2012) Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res (Hoboken) 64(11):1699\u2013707","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"8255_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001050","volume":"5","author":"NW Boone","year":"2019","unstructured":"Boone NW, Sepriano A, van der Kuy PH, Janknegt R, Peeters R, Landewe RBM (2019) Routine assessment of patient index data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice. RMD Open 5(2):e001050","journal-title":"RMD Open"},{"issue":"4","key":"8255_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3899\/jrheum.180178","volume":"46","author":"MD George","year":"2019","unstructured":"George MD, Sauer BC, Teng CC, Cannon GW, England BR, Kerr GS et al (2019) Biologic and glucocorticoid use after methotrexate initiation in patients with rheumatoid arthritis. J Rheumatol 46(4):343\u2013350","journal-title":"J Rheumatol"},{"issue":"6","key":"8255_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landewe RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A et al (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79(6):685\u2013699","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8255_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3899\/jrheum.220152","volume":"50","author":"CF Meng","year":"2023","unstructured":"Meng CF, Rajesh DA, Jannat-Khah DP, Jivanelli B, Bykerk VP (2023) Can patients with controlled rheumatoid arthritis taper methotrexate from targeted therapy and sustain remission? A systematic review and meta-analysis. J Rheumatol 50(1):36\u201347","journal-title":"J Rheumatol"},{"issue":"11","key":"8255_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103423","volume":"22","author":"P Sarzi-Puttini","year":"2023","unstructured":"Sarzi-Puttini P, Zen M, Arru F, Giorgi V, Choy EA (2023) Residual pain in rheumatoid arthritis: is it a real problem? Autoimmun Rev 22(11):103423","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8255_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4078\/jrd.22.0047","volume":"30","author":"DH Lim","year":"2023","unstructured":"Lim DH (2023) A challenging target: persistent pain during the remission state in rheumatoid arthritis patients. J Rheum Dis 30(1):1\u20132","journal-title":"J Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08255-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08255-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08255-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:16:35Z","timestamp":1787022995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08255-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8255"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08255-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KK has received a speaker\u2019s fee from Eli Lilly Japan. All other authors declare no conflicts of interest related to this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}